Support

Resources to navigate psychedelic care with greater confidence.

Explore peer support and a growing library of tools, media, and research to better understand and navigate the impacts of psychedelic treatments. 

Peer support, resources, and lived experience knowledge for patient-centered psychedelic care

We bridge scientific research and clinical practice with the perspectives of people who have lived with diagnoses and undergone psychedelic treatments. 

Whether you’re a clinician, researcher, advocate, patient, trial participant, or caregiver, this space aims to bring together relevant research, conversations, and lived experience insights.

Along with our peer support circles, we’re building a library of podcasts, books, academic research, media, offering nuanced, real-world perspectives on psychedelic research and care.

Join peer-led support circles

Find community in peer-led support groups to process your experiences, integrate insights, and navigate both the breakthroughs and challenges of psychedelic treatments.

These sessions provide a confidential, peer-led and empathetic space to share, reflect, and connect with others who’re walking a similar path.

Whether you're seeking support after a clinical trial or treatment, these peer-led support circles are grounded in lived experience and focused on continued healing through community.

NOTE: Our peer support circles are non-clinical and do not replace medical, psychological, or emergency care.

Status: Open and running

MDMA-assisted therapy peer support circle (online & free)

We're currently running peer support group sessions for those who have legally undergone MDMA-assisted therapy for PTSD through clinical trials or global access programs, including Expanded Access (U.S.), Special Access Program (Canada), Compassionate Use (Switzerland), and the Authorized Prescriber Scheme (Australia). 

Status: Coming soon

Psilocybin-assisted therapy peer support circle (online & free)

We'll be launching a peer support group for those who have legally undergone psilocybin-assisted therapy as a treatment for anxiety, depression, and existential distress through clinical trials or global access programs, including Special Access Program (Canada), Compassionate Use (Switzerland), and the Authorized Prescriber Scheme (Australia).

Status: Coming soon

Ketamine-assisted therapy peer support circle (online & free)

We'll be launching a peer support group for those who have legally undergone ketamine-assisted therapy as a treatment for depression, anxiety, PTSD, or chronic pain through medically supervised clinics.

November 20–22, 2026

Psychedelic Lived Experiences Summit

2026 Theme: Beyond the Protocol

Join a global, multi-stakeholder summit bringing patients, caregivers, clinicians, researchers, and organizations together to examine real-world outcomes, emerging risks, and support gaps after psychedelic treatment.

Get involved

Want to contribute or collaborate? Have a resource to share? We’d love to hear from you! Contact us to submit a resource, recommend a topic, or get involved with our initiatives.

This page will continue to grow as we expand our offerings. Check back for new content and initiatives! 

Illustration of three newsletter cards emerging from an envelope with the Psychedelic Lived Experiences logo, highlighting lived experience stories, psychedelic research and care, and policy and access through images of community, molecular science, and a growing seedling.